GENTA SALUS LLC has a total of 20 patent applications. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and biotechnology are ENGENE INC, BIOVEX LTD and BONE THERAPEUTICS SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Australia | 3 | |
#3 | Canada | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Hong Kong | 2 | |
#6 | Mexico | 2 | |
#7 | United States | 2 | |
#8 | China | 1 |
# | Name | Total Patents |
---|---|---|
#1 | Ruffner Duane E | 12 |
#2 | Wang Laixin | 9 |
#3 | Koehn Richard | 4 |
#4 | Prakash Ramesh | 4 |
#5 | Chen Zhidong | 4 |
#6 | Koehn Richard K | 2 |
#7 | Prakash Ramesh K | 2 |
#8 | Wang Laixin Ruffner Duane E | 1 |
#9 | Laixing Wang | 1 |
#10 | Laixin Wang | 1 |
Publication | Filing date | Title |
---|---|---|
WO2004046327A2 | Inhibitory oliogonucleotides targeted to bcl-2 | |
EP1613722A2 | Rna-based inhibitory oligonucleotides | |
WO2004035759A2 | Inhibitory oligonucleotides targeted to matrix metalloproteinase-9 | |
US2003144222A1 | Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof | |
US7060498B1 | Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |